am I the only one who found biopsy harder than the injections
Long-ish post, sorry. tl;dr at the bottom.
I have been tracking survodutide against eGFR for 15 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here.
Caveats up front: one person, one lab, one assay, no control, and I changed my training in the middle of it, which was stupid.
tl;dr: probably real, definitely smaller than the threads imply, and not worth reorganising your week around.
best — the order this archive was captured in
Spain here. Waited 13 months on a list, gave up, went private, and the total cost was roughly what I expected.
the MASH indication changes the risk calculus
Yeah, glucagon co-agonism is genuinely different.
Not convinced. The evidence does not support that reading.
phase 13 data is interesting, phase 26 will be different
the MASH indication changes the risk calculus
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
Not convinced.
Disagree on that part. 97.4% and 97.6% on the same vial is normal.
the heart rate signal is real in the data
the heart rate signal is real in the data
Yes, exactly this, and it is the bit that took me 5 weeks to accept.
the heart rate signal is real in the data
Maintenance for 3 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
- 1Not convinced. The evidence does not support that reading.5 comments in this branch · started by u/endotoxin_ellie
- 2the heart rate signal is real in the data4 comments in this branch · started by u/injection_site_iris